Drug-Nutrition Interactions and the Brain: It’s Not All in Your Head
- 28 Downloads
Purpose of Review
The interactions between nutrition and medication can be numerous with potential impact on health outcomes. Several subtypes of drug-nutrition interactions exist. Each of these interaction subtypes may influence patients receiving medication for neurologic disorders. After defining drug-nutrition interactions, this review will describe the various types using a handful of widely used central nervous system agents as examples.
Medication may be the object of interactions perpetrated by a specific meal, a food component, a nutrient, or nutrition status thereby altering drug disposition and clinical effect. On the other hand, drugs can influence nutrition status generally or the status of specific nutrients by any number of mechanisms.
Individuals using medication for neurologic disorders are at risk for drug-nutrition interactions of all types.
KeywordsDrug Food Interaction Medication Nutrient Nutrition
Compliance with Ethical Standards
Conflict of Interest
Joseph I. Boullata declares that he has no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance
- 4.Zigmond MJ, Rowland LP, Coyle JT. Neurobiology of Brain Disorders: Biological Basis of Neurological and Psychiatric Disorders. London, UK: Academic Press; 2015.Google Scholar
- 9.Fleisher D, Sweet BV, Parekh A, Boullata JI. Drug absorption with food. In: Boullata JI, Armenti VT, editors. Handbook of Drug-Nutrient Interactions. 2nd ed. New York: Humana Press; 2010. p. 209–41.Google Scholar
- 12.• Sutton SC, Nause R, Gandelman K. The impact of gastric pH, volume, and emptying on the food effect of ziprasidone oral absorption. AAPS J. 2017;19:1084–90 Physiologically-based pharmacokinetic modeling of gut absorption, using published food effect data from a variety of test meals as additional parameter inputs, further improved prediction of ziprasidone absorption profiles based on gastric pH, volume and emptying. CrossRefGoogle Scholar
- 13.• Boudriau S, Hanzel C, Massicotte J, et al. Randomized comparative bioavailability of a novel three-dimensional printed fast-melt formulation of levetiracetam following the administration of a single 1000-mg dose to healthy human volunteers under fasting and fed conditions. Drugs R D. 2016;16:229–38 In a randomized, open-label, crossover study evaluating a new formulation of the antiepileptic drug levetiracetam against the conventional tablet in healthy subjects, the meal effect findings included a much slower rate of absorption without a significant influence on overall drug bioavailability. CrossRefGoogle Scholar
- 20.Bailey DG. Grapefruit and other fruit juices interactions with medicines. In: Boullata JI, Armenti VT, editors. Handbook of drug-nutrient interactions. 2nd ed. New York: Humana Press; 2010. p. 267–302.Google Scholar
- 23.• Johnson EJ, Won CS, Köck K, Paine MF. Prioritizing pharmacokinetic drug interaction precipitants in natural products: application to OATP inhibitors in grapefruit juice. Biopharm Drug Disp. 2017;38:251–9 A well-designed study evaluated seven active compounds found in grapefruit and their relative influence on an important gut uptake transporter using a probe drug in cell culture. Simulated intestinal absorption modeling provided an interesting approach to more widely applying the data. CrossRefGoogle Scholar
- 24.• Chen M, Zhou S-Y, Fabriaga E, Zhang P-H, Zhou Q. Food-drug interactions precipitated by fruit juices other than grapefruit juice: an update review. J Food Drug Anal. 2018;26:S61–71 A recent review that reiterates the findings that juices other than grapefruit juice, including apple, orange and grape juice, may impact drug bioavailability by influencing specific metabolizing enzymes and/or transporters. CrossRefGoogle Scholar
- 25.• Ronis MJJ, Pedersen KB, Watt J. Adverse effects of nutraceuticals and dietary supplements. Annu Rev Pharmacol. 2018;58:583–601 A recent review of dietary supplement products and adverse effects associated with the most commonly used ingredients, and highlighting interactions with medication. CrossRefGoogle Scholar
- 28.Sand PG, Dreiseitel A, Stang M, Schreier P, Oehme A, Locher S, et al. Cytochrome P450 2C19 inhibitory activity of common berry constituents. Phytother Res. 2010;24:304–7.Google Scholar
- 29.• Bahramsoltani R, Rahimi R, Farzaei MH. Pharmacokinetic interactions of curcuminoids with conventional drugs: a review. J Ethnopharmacol. 2017;209:1–12 A review that delves into in vitro, in vivo, clinical and mechanistic data on interactions between the popular curcuminoid compounds of turmeric and medication. CrossRefGoogle Scholar
- 30.• Hyrsova L, Vanduchova A, Dusek J, et al. Trans-resveratrol, but not other natural stilbenes occurring in food, carries the risk of drug-food interaction via inhibition of cytochrome P450 enzymes or interaction with xenosensor receptors. Toxicol Lett. 2019;300:81–91 An elegant mechanistic study in human cell cultures to examine over one dozen stilbenes including resveratrol and describe their influence on a wide range of phase I drug metabolizing enzymes. CrossRefGoogle Scholar
- 32.• Alharbi MH, Lamport DJ, Dodd GF, et al. Flavonoid-rich orange juice is associated with acute improvements in cognitive function in healthy middle-aged males. Eur J Clin Nutr. 2016;55:2021–9 A randomized controlled trial of one serving of flavonoid-enriched orange juice, compared with a calorie-matched placebo, in healthy, middle-aged adults suggests acute cognitive benefits (objective and subjective) over a 6-hour time frame. CrossRefGoogle Scholar
- 33.Anderson KE. Effects of specific foods and dietary components on drug metabolism. In: Boullata JI, Armenti VT, editors. Handbook of drug-nutrient interactions. 2nd ed. New York: Humana Press; 2010. p. 243–65.Google Scholar
- 42.• Beckman LM, Boullata JI, Fisher PL, Compher CW, Earthman CP. Evaluation of lean body weight equation by dual-energy X-ray absorptiometry measures. JPEN J Parenter Enteral Nutr. 2017;41:392–7 A pilot study that suggests that a validated, body composition-based, predictive equation for lean body weight performs much better based on DEXA measures than a commonly used empiric equation in a small group of patients with a wide range of body mass index. CrossRefGoogle Scholar
- 48.Kim YG, Cho MK, Kwon JW, Kim SG, Chung SJ, Shim CK, et al. Effects of cysteine on the pharmacokinetics of phenytoin in rats with protein-calorie malnutrition. Int J Pharm. 2001;229:45–55.Google Scholar
- 50.Abernathy DR, Greenblatt DJ, Divoll M, et al. Enhanced glucuronide conjugation of drugs in obesity: studies of lorazepam, oxazepam, and acetaminophen. J Lab Clin Med. 1983;101:873–80.Google Scholar
- 52.Piccolo KM, Boullata JI. The influence of polypharmacy on nutrition. In: Bendich A, Deckelbaum RJ, editors. Preventive nutrition. 5th ed. New York: Humana Press; 2016. p. 83–113.Google Scholar
- 69.Van Wouwe JP. Carnitine deficiency during valproic acid treatment. Int J Vit Nutr Res. 1995;65:211–4.Google Scholar